Gregory Perry work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Gregory Perry personal email
Gregory Perry phone numbers
Gregory Perry is a CFO Merus N.V. at Merus N.V.. He possess expertise in biotechnology, pharmaceutical industry, mergers and acquisitions, life sciences, venture capital and 13 more skills.
-
CfoMerus N.V. Jun 2023 - PresentUtrecht, Utrecht, Nl -
Audit Committee ChairmanMerus N.V. May 2016 - Jun 2023Utrecht, Utrecht, Nl -
Board MemberKala Pharmaceuticals Mar 2018 - PresentArlington, Massachusetts, Us -
Board Of Director - Biotech; Audit Committee ChairConsultant May 2022 - Jun 2023
-
Chief Financial OfficerFinch Therapeutics Group May 2018 - Apr 2022 -
Chief Financial & Administrative OfficerNovelion Therapeutics Dec 2016 - Dec 2017Boston, UsNovelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. -
Chief Financial & Administrative OfficerAegerion Pharmaceuticals Feb 2016 - Dec 2016Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com.
-
Chief Financial OfficerAegerion Pharmaceuticals Jul 2015 - Feb 2016Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
-
Member Of The Board Of DirectorsRevo Biologics Apr 2014 - Dec 2016
-
Member Of Board Of Directors; Audit Committee Chair; Compensation Committee MemberOcata Therapeutics Dec 2011 - Feb 2016Ocata Therapeutics was acquired by Astellas Pharma in February 2016.
-
Chief Financial And Business OfficerEleven Biotherapeutics Dec 2013 - Jun 2015
-
Interim CfoInvivo Therapeutics Sep 2013 - Dec 2013Cambridge, Ma, Us -
Evp & CfoImmunogen, Inc. Apr 2011 - Sep 2013North Chicago, Illinois, Us -
Svp & CfoImmunogen, Inc. Jan 2009 - Apr 2011North Chicago, Illinois, Us -
CfoElixir Pharmaceuticals Jan 2007 - Dec 2008Us -
CfoDomantis Apr 2006 - Dec 2006Gb -
CfoTkt May 2003 - Aug 2005Us -
CfoPerkinelmer Las 2002 - 2003
-
Svp Finance And Bus. Develop., Life SciencesPki Feb 1998 - Oct 2002Shelton, Ct, Us
Gregory Perry Skills
Gregory Perry Education Details
-
Amherst CollegeEconomics & Political Science
Frequently Asked Questions about Gregory Perry
What company does Gregory Perry work for?
Gregory Perry works for Merus N.v.
What is Gregory Perry's role at the current company?
Gregory Perry's current role is CFO Merus N.V..
What is Gregory Perry's email address?
Gregory Perry's email address is gp****@****ics.com
What is Gregory Perry's direct phone number?
Gregory Perry's direct phone number is +161750*****
What schools did Gregory Perry attend?
Gregory Perry attended Amherst College.
What skills is Gregory Perry known for?
Gregory Perry has skills like Biotechnology, Pharmaceutical Industry, Mergers And Acquisitions, Life Sciences, Venture Capital, Corporate Development, Due Diligence, Finance, Start Ups, Ipo, Lifesciences, Strategy.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial